BOSTON — Fracturing balloon-expandable bioprosthetic transcatheter heart valves (THVs) was associated with an early risk of in-hospital mortality, especially when performed before valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR), a new registry analysis shows.